ARROWHEAD PHARMACEUTICALS, INC. Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss of $1.37 million as of 2021-12-31, per its 10-Q filed 2022-02-02.
Discontinued › Notes › Investments › Debt and Equity Securities › Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss · last filed 2022-02-02
- 2021-12-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $1.37M.
- 2021-09-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $103.00K.
- 2021-03-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $66.00K.
- 2020-12-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $23.00K.
| Period end | Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss | Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss as first filed |
|---|---|---|
| 2021-12-31 | $1.37M 10-Q · filed 2022-02-02 | |
| 2021-09-30 | $103.00K 10-Q · filed 2022-02-02 | |
| 2021-03-31 | $66.00K 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $23.00K 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $79.00K 10-K · filed 2021-11-22 | $79.47K 10-K · filed 2020-11-23 |
| 2020-06-30 | $14.83K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $1.52M 10-Q · filed 2020-05-07 | |
| 2019-06-30 | $84.68K 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $162.80K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $1.00M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $429.05K 10-K · filed 2019-11-25 | |
| 2018-06-30 | $335.33K 10-Q · filed 2018-08-07 | |
| 2017-09-30 | $334.75K 10-K · filed 2018-12-11 | |
| 2017-06-30 | $303.62K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $130.32K 10-Q · filed 2017-05-03 | |
| 2016-03-31 | $122.51K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $159.60K 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $304.94K 10-Q · filed 2016-05-10 | |
| 2015-06-30 | $237.58K 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $412.94K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $579.83K 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $407.52K 10-K · filed 2015-12-14 | |
| 2013-09-30 | $41.64K 10-K · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |